Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Roche
Biotech
Roche returns to Innovent with new $1B biobucks ADC drug deal
Roche has signed a new biobucks-heavy pact that aims to add another new antibody-drug conjugate asset to its pipeline.
Ben Adams
Jan 2, 2025 3:19am
Fierce Medtech’s top 10 stories of 2024
Dec 23, 2024 11:45am
Fierce Biotech's top 10 editor's picks for 2024
Dec 23, 2024 3:00am
Roche's Prothena-partnered Parkinson's prospect fails phase 2b
Dec 19, 2024 4:31am
Roche to bring mass spec to routine labs with new CE Mark
Dec 18, 2024 10:08am
Sanofi, Teva tout midstage win for TL1A antibody in Crohn’s, UC
Dec 17, 2024 10:30am
